Healthcare, biotechnology & medical AI Product
BoneView highlights possible fractures on specified X-rays
Gleamer’s BoneView marks areas that may show a fracture on supported radiographic views. A second FDA filing covers the 1.1-US version and an expanded patient population. [1][2]
What it does
The FDA cleared BoneView on March 1, 2022, under K212365. It cleared BoneView 1.1-US on March 2, 2023, under K222176. The later filing includes children and adolescents in the intended population. [1][2]
Why it matters
The two filings show why the version matters: they describe the same basic fracture-assistance function, and the later version has broader population labeling. [1][2]
Who it’s for
The software is intended to assist healthcare professionals reviewing X-rays within the device’s stated scope. [1][2]
Key dates
Where it fits
BoneView displays candidate regions as image annotations for review alongside the original radiographs. [1][2]
Limits and trade-offs
The cited indications enumerate specific anatomy and views. The decision for version 1.1-US covers the scope described in its own filing. [1][2]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision for BoneView (K212365)
- Primary source FDA 510(k) decision for BoneView (K222176)
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.